Key facts
- This page summarizes David Young's Form 4 filing for Processa Pharmaceuticals, Inc. (PCSA).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 04 Feb 2026, 17:09.
David Young - 01 Jan 2026 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)
- Reporting relationship
- Pres. Research & Development, Director
- Issuer ticker
- PCSA
- Reported as of
- 01 Jan 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 04 Feb 2026, 17:09:36 UTC
- Prior SEC filing
- 03 Oct 2025
- Next SEC filing
- 01 Apr 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ David Young by John J. Wolfel, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
David Young filed Form 4 for Processa Pharmaceuticals, Inc. (PCSA) on 04 Feb 2026.
Change
- Previous filing in this sequence was filed on 03 Oct 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001378166
Primary reporting owner
Young David
- Relationship
- Pres. Research & Development, Director
- Address
- C/O PROCESSA PHARMACEUTICALS, INC., 601 21ST STREET SUITE 300, VERO BEACH
- Signature
- /s/ David Young by John J. Wolfel, as Attorney-in-Fact
- Signature date
- 04 Feb 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PCSA
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +49
- Change %
- +0.56%
- Price
- $0.000000
- Shares after
- 8,752
- Date
- 01 Jan 2026
- Ownership
- Direct
- Footnotes
- F1
PCSA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,242
- Date
- 01 Jan 2026
- Ownership
- By Young-Plaisance Revocable Trust
PCSA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 432
- Date
- 01 Jan 2026
- Ownership
- By Family Entities
PCSA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 742
- Date
- 01 Jan 2026
- Ownership
- By CorLyst, LLC
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PCSA
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -49
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 01 Jan 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 49
- Exercise price
- $0.000000
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Distribution of vested restricted shares.